Peptide Antibiotics Sterile Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Peptide Antibiotics Sterile Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Transparency Market Research
  • Ongoing
  • Pharmaceutical

Report Description


Peptides consist of two or more amino acids connected by amide bonds in a chain form. Covalent chemical bonds are formed when the carboxyl group of one amino acid combines with the other group of amino acid. The peptide molecules are arranged in a linear or cyclic manner. Peptide antibiotics are composed of amino acids, and hence show similarity to gene-encoded polypeptides in terms of structure and mechanism of biosynthesis. Antimicrobial peptides are widely preferred for infectious disease treatment because it consists of short link of amino acid chain (12 to 100 amino acid) and can easily be isolated from single celled microorganisms.

Based on drug class, the global peptide antibiotics sterile injectable drugs market can be segmented into ribosomal synthesized peptides and non-ribosomal synthesized peptides. The ribosomal synthesized peptides segment is likely to expand at a rapid pace during the forecast period, as these peptides have high antimicrobial properties which are helpful in the development of antimicrobial additives and drugs. In terms of application, the market can be categorized into cancer treatment, respiratory disorder therapeutics, cardiovascular disease, central nervous system disorders, and others. The cancer treatment segment is expected to grow significantly due to rise in cancer deaths, which has led to an increased focus of pharmaceutical companies towards the development of new antibiotic drugs to combat the condition.

Based on distribution channel, the global peptide antibiotics sterile injectable drugs market can be classified into hospital pharmacies and retail stores. The hospital pharmacies segment is expected to grow at a rapid pace due to high patient preference to buy peptide antibiotics drugs from hospitals. Rise in prevalence of metabolic disorders and increase in incidence of cancer across the world are the major factors driving the global peptide antibiotics sterile injectable drugs market. Moreover, rise in health awareness is another factors boosting peptide antibiotics sterile injectable drugs market growth. However, the complex manufacturing process of peptide antibiotic sterile injectable drugs is expected to restrain the peptide antibiotics sterile injectable drugs market in underdeveloped countries.

Geographically, the global peptide antibiotics sterile injectable drugs market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe accounted for significant share of the global peptide antibiotics sterile injectable market in 2016 owing to the high rate of diagnosis and treatment of cancer, metabolic disorders, cardiovascular diseases cases, developed medical infrastructure, availability of medical reimbursements, and presence of key market players. According to the Centers for Disease Control and Prevention (CDC), approximately 369.9 to 513.7 per 100,000 persons per year are affected with cancer in the U.S. Moreover, around 300 per 100,000 population per year suffer from cancer in Europe. Apart from cancer, cardiovascular disorder is one of the leading causes of death in North America and Europe. Cardiovascular disease accounts for nearly 3 million deaths in the U.S. each year. The peptide antibiotic sterile injectable drugs market in Asia Pacific is expected to expand at the highest growth rate during the forecast period due to increase in treatment of metabolic disorders, cardiovascular diseases, and availability of generic drugs. Latin America and Middle East & Africa are likely to be moderate contributors to the global peptide antibiotics sterile injectable drugs market.

Major players operating in the global peptide antibiotics sterile injectable drugs market are Abbott Laboratories, Sanofi, Pfizer, Inc., Novartis AG, Eli Lilly and Company, Takeda Pharmaceutical Co. Ltd., and GlaxoSmithKline, among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Have query on this report?

Make an Enquiry

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.


get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074